التفاصيل البيبلوغرافية
العنوان: |
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study. |
المؤلفون: |
Motzer, Robert J, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Alekseev, Boris, Rha, Sun Young, Merchan, Jaime, Goh, Jeffrey C, Lalani, Aly-Khan A, De Giorgi, Ugo, Melichar, Bohuslav, Hong, Sung-Hoo, Gurney, Howard, Méndez-Vidal, MarÃa José, Kopyltsov, Evgeny, Tjulandin, Sergei, Gordoa, Teresa Alonso, Kozlov, Vadim, Alyasova, Anna, Winquist, Eric, Maroto, Pablo, Kim, Miso, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Rodriguez-Lopez, Karla, Burgents, Joseph, He, Cixin, Okpara, Chinyere E, McKenzie, Jodi, Choueiri, Toni K, Galamaga, Rob |
المصدر: |
ENT and Skull Base Surgery |
بيانات النشر: |
Barrow - St. Joseph's Scholarly Commons |
سنة النشر: |
2024 |
نوع الوثيقة: |
text |
اللغة: |
unknown |
العلاقة: |
https://scholar.barrowneuro.org/ent-and-skull-base-surgery/21Test |
DOI: |
10.1200/JCO.23.01569 |
الإتاحة: |
https://doi.org/10.1200/JCO.23.01569Test https://scholar.barrowneuro.org/ent-and-skull-base-surgery/21Test |
رقم الانضمام: |
edsbas.E7F6A072 |
قاعدة البيانات: |
BASE |